Deciphera Pharma, an SJE Group investment based in the USA, has appointed Ron Squarer and Frank S. Friedman to its Board of Directors.
Mr. Squarer served as Chief Executive Officer and a member of the Board of Directors of Array BioPharma from 2012 until its acquisition by Pfizer in August 2019 following the successful commercial launches of both Braftovi® and Mektovi®.
Ron brings over two decades of experience in the biopharmaceutical industry to the Board, with a focus and expertise in oncology drug development, commercialisation, and new product launches.
During his seven-year tenure at Array, Ron executed a research, development, and commercialization strategy focused on oncology that culminated in the acquisition of Array by Pfizer for $11.8 billion. Before joining Array, he held positions of increasing responsibility with Hospira, Inc., a global pharmaceutical and medical device company. As Senior Vice President and Chief Commercial Officer at Hospira, he was responsible for delivering $4 billion in annual revenue. Ron joined Hospira from Mayne Pharma, where he served as Senior Vice President, Global Corporate and Business Development, when Mayne was sold to Hospira in 2007. Before Mayne Pharma, he held leadership roles at both Pfizer (focused on oncology), and SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) in the U.S. and Europe. He currently serves as a member of the Board of Directors of Retrophin, Inc.
Frank S. Friedman
Frank recently served as the global Chief Operating Officer of Deloitte Touche Tohmatsu Limited, a multinational services organization.
He currently serves as Chief Executive Officer at a privately-held finance company. Previously, he worked for Deloitte from 1979 until his retirement from Deloitte in November 2019. During this time, he served in several senior officer positions at Deloitte, including as the global Chief Operating Officer from June 2015 through June 2019. Frank has also served as Deloitte’s US Chief Operating Officer, from June 2015 to June 2017 and Deloitte’s US Chief Financial Officer, from June 2011 through May 2016.
The SJE Group congratulates Ron Squarer, Frank S. Friedman, Steve Hoerter (President and Chief Executive Officer of Deciphera) and the rest of the Board.